What the Mount Raymond acquisition means for SLAM Exploration Ltd.’s Goodwin project scale (TSXV: SXL)
Read More 2 minute read Pharma Industry News Takeda’s HYQVIA reduces CIDP relapse rates, Phase 3 trial reveals Takeda Pharmaceutical Company has disclosed successful outcomes from its critical Phase 3 ADVANCE-CIDP 1 trial, focused on evaluating… byPallavi MadhirajuJune 22, 2023